.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

AVANDARYL Drug Profile

« Back to Dashboard

Which patents cover Avandaryl, and what substitute generic drugs are available?

Avandaryl is a drug marketed by Sb Pharmco and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.

The generic ingredient in AVANDARYL is glimepiride; rosiglitazone maleate. There are fourteen drug master file entries for this compound. Additional details are available on the glimepiride; rosiglitazone maleate profile page.

Summary for Tradename: AVANDARYL

Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: see list82
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AVANDARYL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-001Nov 23, 2005DISCNYesNo7,358,366*PED► SubscribeY► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-003Nov 23, 2005DISCNYesNo7,358,366*PED► SubscribeY► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-002Nov 23, 2005DISCNYesNo7,358,366*PED► SubscribeY► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-004Mar 30, 2007DISCNYesNo7,358,366*PED► SubscribeY► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-005Mar 30, 2007DISCNYesNo7,358,366*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AVANDARYL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-001Nov 23, 20055,002,953*PED► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-003Nov 23, 20055,002,953*PED► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-005Mar 30, 20075,002,953*PED► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-001Nov 23, 20055,741,803*PED► Subscribe
Sb Pharmco
AVANDARYL
glimepiride; rosiglitazone maleate
TABLET;ORAL021700-004Mar 30, 20075,002,953*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: AVANDARYL

Drugname Dosage Strength RLD Submissiondate
glimepiride and rosiglitazone maleateTablets8 mg/2 mg and 8 mg/4 mgAvandaryl5/30/2008
glimepiride and rosiglitazone maleateTablets1 mg/4 mg, 2 mg/4 mg and 4 mg/4 mgAvandaryl12/22/2006
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc